Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-01 Cream in Mild-to-Moderate Psoriasis Vulgaris
NCT03802344Phase 3Completed
- Sponsor
- MC2 Therapeutics
- Start
- Dec 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of calcipotriol + betamethasone in Psoriasis vulgaris (PV), sponsored by MC2 Therapeutics. Started Dec 2018; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT03802344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802344.